about
VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growthABCB5 identifies a therapy-refractory tumor cell population in colorectal cancer patientsStem cells and targeted approaches to melanoma cureMetastatic cancer stem cells: from the concept to therapeuticsProgression of cutaneous melanoma: implications for treatmentABCB5 maintains melanoma-initiating cells through a proinflammatory cytokine signaling circuitSynergy of photoacoustic and fluorescence flow cytometry of circulating cells with negative and positive contrasts.In vivo ultra-fast photoacoustic flow cytometry of circulating human melanoma cells using near-infrared high-pulse rate lasersPhotothermal confocal spectromicroscopy of multiple cellular chromophores and fluorophores.Drug resistance is conferred on the model yeast Saccharomyces cerevisiae by expression of full-length melanoma-associated human ATP-binding cassette transporter ABCB5.Human cancer growth and therapy in immunodeficient mouse models.Nestin depletion induces melanoma matrix metalloproteinases and invasionNovel biomarkers and therapeutic targets for optimizing the therapeutic management of melanomasCirculating Melanoma Cell Subpopulations: Their Heterogeneity and Differential Responses to TreatmentCancer stem cells and their role in metastasisSalmonella VNP20009-mediated RNA interference of ABCB5 moderated chemoresistance of melanoma stem cell and suppressed tumor growth more potently.Genetically determined ABCB5 functionality correlates with pigmentation phenotype and melanoma risk.Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking?Dermis-derived stem cells: a source of epidermal melanocytes and melanoma?Protein and non-protein biomarkers in melanoma: a critical update.Circulating melanoma cells in the diagnosis and monitoring of melanoma: an appraisal of clinical potential.Diversity of assessing circulating tumor cells (CTCs) emphasizes need for standardization: a CTC Guide to design and report trials.Multiplex serum biomarker assessments: technical and biostatistical issues.Minimal residual disease in melanoma: circulating melanoma cells and predictive role of MCAM/MUC18/MelCAM/CD146.Diagnostic microchip to assay 3D colony-growth potential of captured circulating tumor cells.Evaluation of a multi-marker immunomagnetic enrichment assay for the quantification of circulating melanoma cells.Melanoma topology reveals a stem-like phenotype that promotes angiogenesis.Isolation of Circulating Melanoma Cells.Simple and rapid colorimetric detection of melanoma circulating tumor cells using bifunctional magnetic nanoparticles.Phenotypic diversity of patient-derived melanoma populations in stem cell medium.ATP-binding cassette member B5 (ABCB5) promotes tumor cell invasiveness in human colorectal cancer.
P2860
Q24606018-6297800B-F1F7-47D8-A2E9-AC84C41F5236Q24632539-807FAAF8-E143-4C90-8AFA-EA126A130303Q26825014-7601E5D7-FBDC-45E5-9C5F-0E6990577599Q26850739-7D6DD485-045B-4C33-A25F-88026A59EDA0Q27001734-2E831626-7805-4774-931B-AEB4BE6E4A2BQ28242049-7F1505F3-DDA2-4D65-B46A-6F1ED96784BDQ30454851-47098E9A-BF36-48C2-8A72-FE0740C27A75Q30462882-4CC011FA-6CA0-4306-AB77-4171052A006FQ34156257-790B203A-BF20-4877-A069-70095CDF97DDQ34293596-77312A82-19F4-4FB5-912B-372D9835992EQ35545282-26C6AC25-BC7D-49F2-BB24-C71B7AA9446DQ35569170-71A2892A-9A84-4D58-BAED-3A466E60A31EQ35845352-3C93A50D-A9D1-409C-A50F-D94DD1193518Q35858695-B2E8FD77-A07C-4B9B-AC48-6B2304EF0E0BQ36698757-E57EFEF1-3BB6-45AC-AE64-93E5974A5B30Q37046756-89C25CFC-B333-44DD-8F3F-350254796856Q37130096-7562B98B-AB8C-4AD3-BCE8-028F1FB17E55Q37615286-D57343B4-0318-4CAD-9E65-9E729FDDB65EQ37853624-D6C96DAC-44E0-403A-88A8-B218874772C7Q38050990-B1933ACA-4E5E-49F3-A12E-B0C99FE071A2Q38168103-DF73A41A-DFE0-4420-B13C-4A28FC4EAF74Q38577436-A7E78519-8DBD-4ACC-BE5F-A82B05509ABAQ38806499-3B65F719-13CA-4B79-9F5F-79AA78526C44Q39172101-F0352585-8FB9-4C3C-83F1-9F903BABCE00Q39352347-C7936C28-4DAE-4DF2-BFED-49EE498E047BQ41822539-D1E83CE2-2894-433A-B586-2E04490899F8Q42631326-F30178A6-80C0-44FD-B637-0B5AE140B079Q42754442-706862D2-336B-47DB-B258-24A8D8ECB350Q50007021-535D2718-B6D9-44A7-B4D4-2B7ACC0F2081Q51641309-3B0B60E1-779F-4EF8-9BC9-F1CBCBD000F2Q54107810-C904C1A7-98E0-4372-BFA8-ADB23FAEC57E
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Isolation of tumorigenic circulating melanoma cells
@ast
Isolation of tumorigenic circulating melanoma cells
@en
Isolation of tumorigenic circulating melanoma cells
@nl
type
label
Isolation of tumorigenic circulating melanoma cells
@ast
Isolation of tumorigenic circulating melanoma cells
@en
Isolation of tumorigenic circulating melanoma cells
@nl
prefLabel
Isolation of tumorigenic circulating melanoma cells
@ast
Isolation of tumorigenic circulating melanoma cells
@en
Isolation of tumorigenic circulating melanoma cells
@nl
P2093
P2860
P1476
Isolation of tumorigenic circulating melanoma cells
@en
P2093
Allireza Alloo
Ana-Maria Waaga-Gasser
Brian J Wilson
F Stephen Hodi
George F Murphy
Jennifer Y Lin
Markus H Frank
Martin Gasser
Natasha Y Frank
P2860
P304
P356
10.1016/J.BBRC.2010.10.091
P407
P577
2010-10-25T00:00:00Z